| Name | Exendin (5-39) |
|---|
| Description | Exendin (5-39) is a potent glucagon-like peptide 1 (GLP-1) receptor antagonist. Exendin (5-39) improves memory impairment in β-amyloid protein-treated rats[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: GLP-1 receptor[1] |
| In Vivo | Exendin (5-39) (intracerebroventricular injection; 0.3 μg; once daily; 1-week) increases GLT-1 protein levels in the hippocampus of male Wistar rats. Additionally, hippocampal slices are prepared from Ex-treated or vehicle rats,Exendin (5-39) decreases fEPSP decay time and increases the input-output relation and decreased the paired-pulse ratio in the dentate gyrus (DG). Furthermore, Ex inhibits long-term depression but not long-term potentiation in the DG[1]. Animal Model: Wistar rats (3 weeks old and 18 days pregnant)[1] Dosage: 0.3 μg Administration: Intracerebroventricular injection; 0.3 μg; once daily; 1-week Result: Inhibited GLT-1 protein levels and inhibited long-term depression in rats. |
| References |
| Molecular Formula | C169H262N44O54S |
|---|---|
| Molecular Weight | 3806.30 |